| Title : Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia - Walling_2016_Schizophr.Bull_42_335 |
| Author(s) : Walling D , Marder SR , Kane J , Fleischhacker WW , Keefe RS , Hosford DA , Dvergsten C , Segreti AC , Beaver JS , Toler SM , Jett JE , Dunbar GC |
| Ref : Schizophr Bull , 42 :335 , 2016 |
| Abstract : Walling_2016_Schizophr.Bull_42_335 |
| ESTHER : Walling_2016_Schizophr.Bull_42_335 |
| PubMedSearch : Walling_2016_Schizophr.Bull_42_335 |
| PubMedID: 26071208 |
Walling D, Marder SR, Kane J, Fleischhacker WW, Keefe RS, Hosford DA, Dvergsten C, Segreti AC, Beaver JS, Toler SM, Jett JE, Dunbar GC (2016)
Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia
Schizophr Bull
42 :335
Walling D, Marder SR, Kane J, Fleischhacker WW, Keefe RS, Hosford DA, Dvergsten C, Segreti AC, Beaver JS, Toler SM, Jett JE, Dunbar GC (2016)
Schizophr Bull
42 :335